Caribou Biosciences, Inc. (CRBU) Operating margin 2019–2025
Caribou Biosciences, Inc. (CRBU) operating margin by fiscal year — reported operating income divided by reported revenue.
-1329.4%FY2025 · since FY2019: -592.7% → -1329.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1329.4% | +337.8 pp |
| FY2024 | -1667.2% | -1330.5 pp |
| FY2023 | -336.6% | +431.5 pp |
| FY2022 | -768.2% | -70.3 pp |
| FY2021 | -697.8% | -405.6 pp |
| FY2020 | -292.2% | +300.5 pp |
| FY2019 | -592.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice